A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: RPT193; Drug: Placebo Sponsor: RAPT Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials